Latest Period
Q2 2026
Security Snapshot
Milestone Pharmaceuticals Inc. - Common Shares, no par value (MIST) Institutional Ownership
CUSIP: 59935V107
13F Institutional Holders and Ownership History from Q2 2019 to Q2 2026
Institutions Reporting
78
Shares (Excl. Options)
49,554,243
Price
$1.34
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Shares, no par value
- Symbol
- MIST on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 49,554,243
- Total 13F value
- $66,401,637
- Portfolio coverage rank
- 0%
- Share change
- +10,059,431
- Value change
- +$13,835,696
- Number of holders
- 78
- Shares outstanding
- 124,217,096
- SEC-reported price per share
- $1.04
- Insider filing price
- $1.04
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- MIST - Milestone Pharmaceuticals Inc. - Common Shares, no par value is tracked under CUSIP 59935V107.
- 78 institutions reported positions in Q2 2026.
- 6 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 87 to 78 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $47,216,565 to $66,401,637.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 78 institutions filings for Q2 2026.
Security key
59935V107
Latest holder period
Q2 2026
13F holders
78
13D/G owners
6
CIK / CUSIP context first
Open Q2 2026 holders
MIST full holder history
Milestone Pharmaceuticals Inc. SEC filings
Milestone Pharmaceuticals Inc. company facts
Milestone Pharmaceuticals Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 59935V107:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
6
Security
MIST
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 9.9% | 0% | $24,713,906 | +$6,403,570 | 12,356,953 | +35% | RTW Investments, LP | 31 Mar 2026 |
| Pavaki Capital Management LLC | 7.3% | $11,878,881 | 9,067,848 | Pavaki Capital Management LLC | 31 Dec 2025 | |||
| Propel Bio Management, LLC | 9.9% | $21,001,011 | 8,861,186 | Propel Bio Management, LLC | 11 Jul 2025 | |||
| Adage Capital Management, L.P. | 6.4% | -36% | $16,000,000 | -$1,318,128 | 8,000,000 | -7.6% | Adage Capital Management, L.P. | 31 Mar 2026 |
| Trails Edge Capital Partners, LP | 4.3% | -56% | $9,013,333 | -$6,226,884 | 5,333,333 | -41% | Trails Edge Capital Partners, LP | 20 Mar 2026 |
| INTEGRATED CORE STRATEGIES (US) LLC | 0.6% | $396,161 | 322,082 | Integrated Core Strategies (US) LLC | 31 Mar 2025 |
As of 30 Jun 2026, 78 institutional investors reported holding 49,554,243 shares of Milestone Pharmaceuticals Inc. - Common Shares, no par value (MIST). This represents 40% of the company’s total 124,217,096 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
39%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Pavaki Capital Management LLC | 7.3% | 9,067,848 | +0.06% | 6.9% | $12,150,916 |
| RTW INVESTMENTS, LP | 6.3% | 7,833,336 | +24% | 0.09% | $10,496,670 |
| Propel Bio Management, LLC | 6% | 7,429,590 | +80% | 5.2% | $9,955,651 |
| Point72 Asset Management, L.P. | 4.4% | 5,411,138 | +398% | 0.01% | $7,250,925 |
| Simplify Asset Management Inc. | 2.7% | 3,349,379 | +122% | 0.06% | $4,488,168 |
| MILLENNIUM MANAGEMENT LLC | 2.5% | 3,142,219 | +103% | 0% | $4,210,573 |
| TWO SIGMA INVESTMENTS, LP | 1.6% | 2,040,015 | -12% | 0% | $2,733,620 |
| MARSHALL WACE, LLP | 1.4% | 1,797,695 | -7.6% | 0% | $2,408,911 |
| Kalehua Capital Management LLC | 1% | 1,269,237 | 0.98% | $1,700,778 | |
| Lion Point Capital, LP | 0.66% | 820,000 | 0% | 5.3% | $1,098,800 |
| TORONTO DOMINION BANK | 0.6% | 750,000 | 0% | 0% | $1,005,000 |
| AMERIPRISE FINANCIAL INC | 0.54% | 666,666 | 0% | 0% | $893,332 |
| Boxer Capital Management, LLC | 0.54% | 666,666 | 0% | 0.07% | $893,332 |
| MORGAN STANLEY | 0.51% | 635,211 | -12% | 0% | $851,183 |
| UBS Group AG | 0.37% | 465,403 | -6% | 0% | $623,641 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.37% | 462,669 | +174% | 0.01% | $619,976 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.29% | 359,895 | -31% | 0% | $482,259 |
| Aptus Capital Advisors, LLC | 0.27% | 339,450 | +21% | 0% | $454,863 |
| GUARDIAN WEALTH ADVISORS, LLC / NC | 0.27% | 339,450 | +21% | 0.03% | $454,863 |
| Seven Fleet Capital Management LP | 0.22% | 270,233 | -19% | 0.06% | $362,112 |
| Squarepoint Ops LLC | 0.19% | 231,824 | -31% | 0% | $310,644 |
| LPL Financial LLC | 0.18% | 220,873 | +14% | 0% | $295,970 |
| Balyasny Asset Management L.P. | 0.18% | 220,498 | -74% | 0% | $295,467 |
| BNP PARIBAS FINANCIAL MARKETS | 0.14% | 173,704 | 0% | 0% | $232,763 |
| TRU INDEPENDENCE ASSET MANAGEMENT 2, LLC | 0.12% | 150,000 | +50% | 0.11% | $201,000 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
29
Latest
Q2 2026
Rows shown
1-25 of 29
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 49,554,243 | $66,401,637 | +$13,835,696 | $1.34 | 78 |
| 2026 Q1 | 39,527,612 | $47,216,565 | +$1,536,619 | $1.19 | 87 |
| 2025 Q4 | 26,494,301 | $53,565,472 | -$15,312,984 | $2.02 | 79 |
| 2025 Q3 | 34,138,461 | $68,276,752 | +$44,826,873 | $2.00 | 61 |
| 2025 Q2 | 11,817,806 | $22,925,663 | +$893,027 | $1.94 | 43 |
| 2025 Q1 | 11,824,370 | $9,461,152 | -$26,033,743 | $0.80 | 43 |
| 2024 Q4 | 24,552,580 | $57,943,143 | -$9,780,800 | $2.36 | 46 |
| 2024 Q3 | 28,677,385 | $43,589,418 | -$2,288,268 | $1.52 | 41 |
| 2024 Q2 | 30,178,631 | $39,890,373 | -$1,767,212 | $1.32 | 39 |
| 2024 Q1 | 31,068,273 | $55,610,121 | +$23,911,141 | $1.79 | 40 |
| 2023 Q4 | 17,804,637 | $29,733,304 | -$3,789,133 | $1.67 | 40 |
| 2023 Q3 | 19,572,198 | $60,672,803 | -$3,310,719 | $3.10 | 39 |
| 2023 Q2 | 20,687,365 | $58,958,957 | -$3,141,348 | $2.85 | 48 |
| 2023 Q1 | 21,710,779 | $85,540,237 | -$9,705,873 | $3.94 | 49 |
| 2022 Q4 | 23,737,827 | $94,006,246 | -$28,853,317 | $3.96 | 55 |
| 2022 Q3 | 20,398,285 | $187,452,026 | +$10,127,011 | $9.19 | 43 |
| 2022 Q2 | 20,825,690 | $127,165,640 | -$2,809,102 | $6.15 | 29 |
| 2022 Q1 | 21,048,124 | $135,124,913 | +$5,027,454 | $6.42 | 28 |
| 2021 Q4 | 20,243,658 | $132,596,706 | +$1,818,999 | $6.55 | 27 |
| 2021 Q3 | 19,956,009 | $113,947,594 | -$1,093,248 | $5.71 | 26 |
| 2021 Q2 | 20,148,798 | $110,818,750 | -$885,245 | $5.50 | 26 |
| 2021 Q1 | 20,284,874 | $117,447,374 | -$1,995,259 | $5.79 | 31 |
| 2020 Q4 | 20,571,334 | $137,829,226 | +$33,967,631 | $6.70 | 33 |
| 2020 Q3 | 15,483,607 | $113,344,014 | +$42,783,062 | $7.32 | 29 |
| 2020 Q2 | 9,754,497 | $36,871,064 | +$2,941,736 | $3.78 | 23 |